Radioimmunoassay Market Key Companies Profile and SWOT Analysis by 2031

Radioimmunoassay Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type (Reagents and Kits, Analyzers Market); Application (Research, Clinical Diagnostics); End User (Hospital, Pharmaceutical Industry and CRO, Academics, Clinical Diagnostic Laboratories), and Geography (North America, Europe, Asia Pacific, and South and Central America)

Historic Data: 2021-2023   |   Base Year: 2024   |   Forecast Period: 2025-2031
  • Report Date : Apr 2026
  • Report Code : TIPRE00006186
  • Category : Life Sciences
  • Status : Upcoming
  • Available Report Formats : pdf-format excel-format
  • No. of Pages : 150
Radioimmunoassay Market Key Companies Profile and SWOT Analysis by 2031
Report Date: Apr 2026   |   Report Code: TIPRE00006186
Buy Now
Page Updated: Feb 2026

The Radioimmunoassay Market size is expected to reach US$ 653.32 million by 2031. The market is anticipated to register a CAGR of 3.8% during 2025–2031.

The Radioimmunoassay Market report covers analysis By Type (Reagents and Kits, Analyzers Market); Application (Research, Clinical Diagnostics); End User (Hospital, Pharmaceutical Industry and CRO, Academics, Clinical Diagnostic Laboratories). The global analysis is further broken-down at regional level and major countries. The Report Offers the Value in USD for the above analysis and segments.

Purpose of the Report

The report Radioimmunoassay Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:

  1. Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
  2. Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
  3. Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.

Radioimmunoassay Market Segmentation Type

  1. Reagents and Kits
  2. Analyzers Market

Application

  1. Research
  2. Clinical Diagnostics

End User

  1. Hospital
  2. Pharmaceutical Industry and CRO
  3. Academics
  4. Clinical Diagnostic Laboratories

Geography

  1. North America
  2. Europe
  3. Asia-Pacific
  4. South and Central America
  5. Middle East and Africa

Customize This Report To Suit Your Requirement

Get FREE CUSTOMIZATION

Radioimmunoassay Market: Strategic Insights

radioimmunoassay-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Radioimmunoassay Market Growth Drivers

  1. Increasing Demand for RIA: The rise in chronic diseases and hormonal imbalances has led to a higher demand for radioimmunoassay (RIA) as a sensitive and precise diagnostic tool, contributing to market growth.
  2. Global Healthcare Expenditure Driving Market Expansion: The increase in global healthcare expenditure and the growing need for accurate diagnoses are fueling the expansion of the RIA market, as noted in PEST analysis.
  3. Advancements in RIA Technology: Technological improvements are enhancing the sensitivity, specificity, and automation of radioimmunoassay, making it more clinically and research-relevant, which boosts market adoption.

Radioimmunoassay Market Future Trends

  1. Increasing Demand in Disease Diagnosis: The rise in disease prevalence is driving the demand for sensitive diagnostic tools for chronic diseases. Key players are focused on improving precision, leading to optimistic market forecasts driven by healthcare demand.
  2. Technological Advancements: Innovations in radioimmunoassay (RIA) have transformed the market, with a focus on enhancing accuracy through automation. Continued market growth is expected as companies refine their technologies.
  3. Applications in Research: RIA’s use in academic and clinical research supports market growth, particularly in drug discovery. Key players are focusing on partnerships with research institutions, which foster dynamic market growth.

Radioimmunoassay Market Opportunities

  1. Hormonal and Metabolic Disorder Testing: The rising prevalence of disorders like thyroid imbalances presents a significant growth opportunity for radioimmunoassay applications. Companies offering accurate hormone assays can capture market share, particularly in regions with high chronic disease rates.
  2. Advanced Cancer Diagnostics: Radioimmunoassays offer novel solutions for detecting specific cancer markers, driving innovation and growth in cancer diagnostics, particularly in North America and Europe’s healthcare sectors.
  3. Research and Drug Development: RIA plays a crucial role in pharmaceutical research, enabling clinical trials and therapeutic progress. Companies can capitalize on the demand from global research institutions, potentially shifting market trends and redefining the industry landscape.

Radioimmunoassay Market Report Scope

Report Attribute Details
Market size in 2024 US$ XX Million
Market Size by 2031 US$ 653.32 Million
Global CAGR (2025 - 2031) 3.8%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Type
  • Reagents and Kits
  • Analyzers Market
By Application
  • Research
  • Clinical Diagnostics
By End User
  • Hospital
  • Pharmaceutical Industry and CRO
  • Academics
  • Clinical Diagnostic Laboratories
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • DIAsource ImmunoAssays
  • Beckman Coulter, Inc.
  • IBL International (A Tecan Company)
  • PerkinElmer, Inc.
  • DRG International, Inc.
  • MP Biomedicals, LLC
  • Cisbio
  • Euro Diagnostica AB
  • DiaSorin S.p.A.
  • EMD Millipore

Radioimmunoassay Market Players Density: Understanding Its Impact on Business Dynamics

The Radioimmunoassay Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

radioimmunoassay-market-cagr

Key Selling Points

  1. Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Radioimmunoassay Market, providing a holistic landscape.
  2. Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
  3. Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
  4. Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.

The research report on the Radioimmunoassay Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.


Frequently Asked Questions

The Radioimmunoassay Market is estimated to witness a CAGR of 3.8% from 2025 to 2031.

Key future trends in this market are - Increasing Demand in Disease Diagnosis, Technological Advancements, Research and Academic Applications

Key companies of this market are: Ancestry, 23andMe Inc, Gene By Gene Ltd, Mapmygenome, Pathway Genomics, Veritas, Myriad Genetics Inc, Illumina Inc, Amgen Inc.

Some of the customization options available based on request are additional 3-5 company profiles and country-specific analysis of 3-5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.

The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.

The major factors driving the Market are: Growing diagnostic test demand, Technological improvements in RIA, Healthcare investment in emerging markets
Mrinal Kerhalkar
Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
Chat with us
DUNS Logo
87-673-9708
ISO Certified Logo
ISO 9001:2015
GDPR
CCPA